Vericel Corporation (VCEL) Stock Price, Quote & News

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 588 5555

Fax: 617 588 5554

Website: www.vcel.com

Address:

25 Blue Sky Drive, Burlington, United States

Pro_From_Dover Aug. 19 at 1:53 PM

$VCEL ran up to 46 just immediately plunge to negative territory at the open? What the heck???

1 · Reply

Pro_From_Dover Aug. 17 at 3:30 PM

$VCEL different day, new week, same crap.

2 · Reply

Pro_From_Dover Aug. 13 at 4:13 PM

$VCEL absolute dog

0 · Reply

cush6 Aug. 13 at 12:00 PM

$VCEL 08/13/2026 Nexobrid news.... Vericel reported NexoBrid’s strongest quarter since launch, with record quarterly revenue, hospital unit sales and ordering centers. Approximately 80 burn centers have ordered NexoBrid since launch, reflecting continued adoption and increasing utilization across the U.S. burn care market. Following Vericel’s 10-year contract with BARDA, valued at up to $197 million (the “BARDA Contract”), the Company and Vericel entered into a Master Services Agreement (the “MSA”) covering NexoBrid and next-generation product development activities. Under the MSA, the Company expects to begin recognizing revenue in the second half of 2026 by participating in a next generation development program that has been initiated to support the potential expansion of NexoBrid for use in blast- and friction-related injuries, leveraging real-world evidence.

0 · Reply

JFDI Aug. 11 at 6:47 PM

$VCEL monthly MacD cross.

0 · Reply

Pro_From_Dover Aug. 10 at 2:01 PM

$VCEL so much positive opportunities and we’re down like 10% since earnings? Pitiful on so many levels

0 · Reply

Bulski69 Aug. 7 at 6:56 PM

$VCEL low float situation here looking promising 💪

0 · Reply

Pro_From_Dover Aug. 5 at 1:45 PM

$VCEL time and again this proves how weak and anemic it is as a security. Company/management has no clear plan nor apparent ability to ensure that corporate success and growth is matched by share appreciation. Or perhaps they either don’t want to or have no incentive for such shared benefit. Thus, despite an excellent benchmark report, perhaps the best that could have been delivered, share appreciation dips and settles low once again.

0 · Reply

jamco44 Aug. 1 at 2:05 AM

$VCEL This was as close as you can get to a blowout quarter. And A Share buyback. And we go down today. i cant explain this. Holding for 20 years. Maybe management thought they would throw a bone? I still say get some young aggressive CEO. I feel like there hanging on to what they know.

5 · Reply

cush6 Jul. 31 at 7:37 PM

$VCEL TD cowan raises VCEL target to buy $58

0 · Reply

Vericel price target raised to $58 from $55 at TD Cowen

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Vericel Earnings Call Transcript: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Vericel Slides: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Vericel Earnings release: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Vericel Quarterly report: Q2 2026

2026-07-30T12:05:29.000Z - 20 days ago

Vericel reports Q2 EPS 4c, consensus (3c)

2026-07-30T12:05:18.000Z - 20 days ago

Vericel raises FY26 revenue view to $330M-$340M from $326M-$336M

Jul 30, 2026, 7:55 AM EDT - 20 days ago

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

2026-07-16T14:10:17.000Z - 4 weeks ago

Vericel price target raised to $54 from $42 at Truist

Jul 16, 2026, 8:30 AM EDT - 4 weeks ago

Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026

Jun 16, 2026, 11:20 AM EDT - 2 months ago

Vericel Transcript: Truist Securities MedTech Conference 2026

Jun 16, 2026, 11:20 AM EDT - 2 months ago

Vericel Slides: FY 2026

Jun 9, 2026, 8:30 AM EDT - 2 months ago

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

2026-05-08T10:29:58.000Z - 3 months ago

Vericel price target raised to $70 from $64 at H.C. Wainwright

2026-05-07T19:06:49.000Z - 3 months ago

Vericel reports Q1 EPS (12c), consensus (16c)

2026-05-07T19:04:46.000Z - 3 months ago

Vericel raises FY26 revenue guidance to $326M-$336M from $316M-$326M

May 7, 2026, 8:30 AM EDT - 3 months ago

Vericel Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Vericel Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Vericel Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Vericel Quarterly report: Q1 2026

May 7, 2026, 7:45 AM EDT - 3 months ago

Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

Apr 29, 2026, 9:00 AM EDT - 4 months ago

Vericel Transcript: AGM 2026

Apr 23, 2026, 8:30 AM EDT - 4 months ago

Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

2026-04-15T12:49:05.000Z - 4 months ago

Vericel price target lowered to $42 from $48 at Truist

2026-04-02T19:37:47.000Z - 4 months ago

MediWound says Vericel awarded ten-year contract valued at up to $197M

MDWD

Apr 2, 2026, 2:40 PM EDT - 4 months ago

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

2026-04-02T17:30:15.000Z - 4 months ago

Vericel awarded Health and Human Services contract valued at $196.87M

Mar 19, 2026, 8:00 AM EDT - 5 months ago

Vericel Proxy statement: Proxy filing

Mar 19, 2026, 8:00 AM EDT - 5 months ago

Vericel Proxy statement: Proxy filing

Mar 10, 2026, 8:40 AM EDT - 5 months ago

Vericel Transcript: Leerink Global Healthcare Conference 2026

Mar 4, 2026, 9:50 AM EST - 6 months ago

Vericel Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-04T13:05:09.000Z - 6 months ago